Meet Ema.
The women's health AI.

The Problem

~60%

of women's health scenarios fail across the 13 leading LLMs

Gruber et al., A Women's Health Benchmark for Large Language Models, arXiv 2025.

Yet, 75% of U.S. health companies are betting on AI.

Without cohesive context, general AI is forced to guess.

Under-researched

Women were excluded from most clinical trials until 1993.NIH Revitalization Act, 1993

Unrepresentative

Dosing and diagnostics were rarely validated for women.Nature Reviews Bioengineering (2024), “Funding research on women's health.”

Complex

Ovarian aging reshapes everything; the data never connects.Mayo Clinic, “How menopause affects heart, brain and bone health”

The solution

Ema turns general AI into
women's health intelligence
any organization can trust and deploy.

InputAny frontier modelGeneral-purpose, male-baselined

→

EmaemaeqClinical rubrics · guardrails · 10M+ conversations

→

OutputContext-aware guidanceEvidence-based, safe, and actionable

So What?

Care falls apart between visits. Ema is the longitudinal care navigator.

Care happens in the weeks between appointments. Exactly when no one is checking on the patient.

01

Gaps

Missed screenings, follow-ups, and preventive care.

Care gets missed

02

Disconnected dots

Symptoms and data accumulate, but no one links them together.

Context gets lost

03

Drift

Without support in the moment, patients don’t take the next healthy action.

Momentum disappears

Real-world partner example

A woman with a psoriasis flare, trying to get into a clinical trial.

×Takeda clinical trial

01Ema routes

Get her the at-home diagnostic

Diagnostics

02Ema matches

Enroll her in a clinical trial

Research

03Ema unlocks

Find medication support

Access

04Ema briefs

Give her doctor what they need

Care team

MMaya, 34recurring
psoriasis flares

Viewed alongside Maya’s clinical records, those in-between moments create a more complete longitudinal story.

Maya's longitudinal care record6 of 8 entries added by Ema

Flare pattern14 monthsHer journey

Raspberry IgE2023, resurfacedEma

Med response2 agents failedPharmacy

Dietary triggernot seasonalEma

At-home panelrouted to her doorEma

CoverageSDOH + couponEma

Trial eligibilitynow recruitingEma

Care summaryready to shareEma

Women’s health intelligence

Ema supercharges health and wellness outcomes (safely)

In women's health, a raw model is an astronaut with no suit.

She asks“I'm exhausted, nauseous, and my jaw aches.”

Raw model

“Try gently massaging your jaw or applying a warm compress.”

● Misses a heart attack.

Ema

“Jaw ache and nausea can signal a heart problem, especially in women, where it shows up without chest pain.”

● Catches the red flag. Escalates. Uses her history.

Ema's proprietary DNA

Astronaut = any frontier model, swappable · Suit = Ema, running on our hybrid language model

TL;DRThe LLM missed a woman having a heart attack. Ema didn't.

Commercial validation

We are already building the foundation with organizations across the health ecosystem.

Diagnostics

Bring the right test into the journey

Guides users to appropriate at-home testing and helps them understand the next step.

FDA + research

Test label comprehension before FDA studies

Runs think-aloud interviews and flags where people misread the package or Drug Facts Label.

Chronic care

Connect labs to behavioral support between visits

Explains results, delivers PHQ-9 and GAD-7 assessments, and escalates acute risk.

Pediatric allergies

Guide families through symptoms and next steps

Educates caregivers on triggers and reactions, escalating questions that need physician review.

Emergency contraception

Support informed decisions without product bias

Explains options, timing, and efficacy without steering users toward a specific product.

Hormone health

Turn cycle and symptom data into a personal care plan

Connects VIP user data to conversational guidance, assessments, and clinical escalation.

More organizations we’re building with

74%

WearablesPreferred response

2×

Digital healthEngagement

52%

Pharma & diagnosticsGuided to a doctor

Proof

It works in the real world.

One conversation supports the patient and becomes structured quality data the care team can act on.

Her view

EmaYour women’s health companion

● Live

I’ve been feeling really low since the baby arrived. Is this normal?

I’m glad you told me. I can check in with a few questions and help you decide what support makes sense next.

Yes, please.

Let’s start together. Over the past seven days, have you been able to laugh and see the funny side of things?

Tell me in your own words...

Start check-inTalk to someone

Your view

HEDIS-aligned qualityConcern identified, addressed, and navigated to the right next step.

Live capture

Structured, de-identified signal from the conversation.

4 quality measures

Journey momentPostpartum follow-up

ConcernDepression symptoms

AssessmentEPDS / PHQ-9

Next stepNavigate and escalate

99.1%

Prenatal & postpartum

Quality measure met

98.1%

Chronic pain

Quality measure met

89%

Depression follow-up

EPDS / PHQ-9

87.5%

Breast screening

ACOG / ACS aligned

Engagement since Ema launched

30-day index

100

200+

2×

More engagement

Partner platform with 200,000 monthly active users.

What we built

We built what general-purpose LLMs missed in plain sight.

History proves this…

5%

of global R&D funding has gone to women's health for decades.

Nature Reviews Bioengineering (2024), “Funding research on women's health.”

Our differentiators: Purpose-built for accuracy, accountability, and compliance in women’s health, not bolted on after the fact.

Cheaper

Predictable pricing.

Trusted

Conflict and bias monitoring.

Transparent

Analytics across every conversation.

Reduced Risk

Human-in-loop QA. HIPAA & SOC 2.

Modular

One capability or the whole layer.

Ownership

IP stays in the partner environment.

Market

We proved demand in women’s health. Now we scale into clinical care.

TAM$2.0TWomen's health across wellness, tech-enabled health, diagnostics & pharma

SAM$500BReachable with Ema's layer

SOM$110MObtainable near-term

Ideal Customer Profiles

1

Health & wellness brands

Proven wedge

Consumer-driven products, wearables, and services.

SAM $250BAvg customer $250Ke.g. Julie

2

Diagnostics, pharma & FDA programs

Now

At home diagnostics, hormonal testing, virtual pharmacy, FDA research.

SAM $150BAvg customer $500Ke.g. Let's Get Checked

3

Health systems & tech-enabled care

EHR-connected care, telehealth, fertility, GLP-1, allergies, and clinical trials.

SAM $100BAvg customer $350Ke.g. Patients Like Me

Sources: McKinsey, WHO, GlobalData, Fortune, Statista, Grand View.

Traction

Our market traction to-date

ARR Growth: 2026–2028

$1M

YE 26

$4.5M

YE 27

$12M

YE 28

Projected

*Totals in chart above are cumulative

✦Growth Metrics

2025 → 2026 Expected Growth

396%

✦Active Pipeline

$12M

Total Pipeline Value

Avg Deal Size$125K

Average deal2-year, with auto-renewal

$3M

Signed in contract value to date*

*Contracts signed, LOI received, or pending deployment in actual contract value

Who's building it

Meet the team that built the first agentic AI for women, circa 2019 ✦

CEO

Amanda Ducach

Serial tech entrepreneur,
sales strategist
15+ yrs

CTO

Vish Sharma

Serial entrepreneur
Data scientist & architect
15+ yrs

CXO

Karishma Patel

Scrum-certified, CX
10+ yrs

CSO

Morgan Rose

WHNP-BC, CNM & IBCLC
15+ yrs

AI Biologist

Russ Foltz-Smith

OpenAI Ambassador,
Microsoft MVP
25+ yrs

Head of Finance

Chris Scudellari

CPA, Partner at EY
for 40+ years

Medical Advisory Board

Peds &
Internal Med

Lifestyle &
Emergency Med

OBGYN

Emergency
Med

Team alumni: BlueCross BlueShield, Microsoft, OpenAI, Clue, UChicago Medicine, Starbucks, Match, WolframAlpha, Marriott, EY

Why teams trust Ema

Recognized, awarded, and setting the standard.

Forbes: AI-Powered Women's Health, Ema's Mission To Combat Bias

Entrepreneur: These Founders Are Building Healthcare Companies for the People the System Keeps Missing

Forbes: 60% AI Failure Rate In Women's Health, Standards Are Coming

Serena Williams highlighting Reckitt Catalyst and Acumen America cohort

We are co-founders of the WHAI Consortium

AI Innovation of the Year 2025

The ask

We're raising a PRICED round.

$3.5Mraised to date

Backed by

Hearst Lab, Kubera Venture Capital, Wormhole, Techstars, Emmeline Ventures, Victorum Capital, Acumen

Use of proceeds: clinical scale, enterprise distribution, and a path to profitability

0–12 MONTHS

Clinical infrastructure

Deepen medical content, guardrails, escalation protocols, and EHR-ready integrations.

→

12–24 MONTHS

Enterprise scale

Expand across health systems, diagnostics, pharma, and tech-enabled care.

→

24+ MONTHS

Self-serve + profitability

Launch a repeatable developer platform and convert clinical adoption into durable growth.

Meet Ema.The women's health AI.

Ema turns general AI intowomen's health intelligenceany organization can trust and deploy.